Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclophosphamide Added to Rd in Multiple Myeloma with Biochemical Progression
NCT02206503Phase 2Completed
- Sponsor
- Fondazione EMN Italy
- Start
- Mar 2013
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cyclophosphamide in multiple myeloma (MM), sponsored by Fondazione EMN Italy. Started Mar 2013; status: completed.
02
Drugs
cyclophosphamide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT02206503.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02206503.